Phathom Pharmaceuticals, Inc. PHAT Total debt

Total debt at other companies

Rigel PharmaceuticalsRIGL

$68.36M+5,079%

Opko HealthOPK

$49.94M-7.5%

Cumberland PharmaceuticalsCPIX

$4.71M-7.6%

Mirum Pharmaceuticals, Inc.MIRM

$12.87M+29.2%

Roivant SciencesROIV

$107.15M+7.5%

Aquestive Therapeutics, Inc.AQST

$63.38M+6.0%

FAQ

What is Phathom Pharmaceuticals, Inc.'s total debt?

Phathom Pharmaceuticals, Inc. (PHAT) reported total debt of $167.11M in Q2 2026.

How has Phathom Pharmaceuticals, Inc.'s total debt changed year-over-year?

Phathom Pharmaceuticals, Inc.'s total debt decreased by 18.9% year-over-year, from $205.97M to $167.11M.

What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total debt?

Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total debt has grown at a 34.0% compound annual growth rate (CAGR), from $49.02M to $211.8M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.